Sotera Health Reports Third-Quarter and Year-to-Date 2023 Results

01.11.2023 - Q3 2023 net revenues of $263 million increased 6%, compared to Q3 2022Q3 2023 net loss of $14 million or $0.05 per diluted share, compared to net income of $25 million or $0.09 per diluted share in Q3 2022 Q3 2023 Adjusted EBITDA of $134 million ...

Related Keywords

Russia ,Illinois ,United States ,Delaware ,United Kingdom ,Georgia ,New Mexico ,Canada ,Willowbrook ,Canadian ,Kristin Gibbs ,Jason Peterson ,Michaelb Petras Jr ,Sotera Health Company ,Sotera Health ,Wolfe Research Conference ,Presentation Events Sotera Health ,Investor Relations Sotera Health ,Global Health ,Regulatory Compliance Associates Inc ,United Kingdom Or European Union ,Chief Executive Officer ,Safeguarding Global Health ,Nelson Labs ,Adjusted Net Income ,Net Leverage Ratio ,Note Regarding Forward Looking Statements ,Investor Relations ,Research Conference ,European Union ,Net Debt ,Adjusted Net ,Health Company ,Safeguarding Global ,Marketing Officer ,Bioscience Labs ,Medical Isotopes ,Settlement Agreements ,Settling Defendants ,Consolidated Statements ,Regulatory Compliance Associates ,Months Ended September ,Represents Adjusted ,Months Ended December ,Sotera Health Company Chart ,Otera Health Company Kurs ,Otera Health Company Aktie ,